Grab2Go (GRB2G) H1 2026 earnings summary

Executive summary

• Focused on developing unmanned, robotized retail technology for pharmacies, fuel stations, and convenience stores, with primary sales efforts in the pharmaceutical sector.

• No new material business developments in H1 2026; ongoing projects and market positions unchanged from 2025.

• Regulatory clarity and additional capital are essential for broader commercialization, especially in self-service pharmacies.

Financial highlights

• Revenue for H1 2026 was €0, down from €2,420 in H1 2025, a 100% decrease year-over-year.

• Net loss for H1 2026 was €62,448, an 18.4% reduction from €76,522 in H1 2025.

• Operating expenses (excluding depreciation/amortization) were €8,220, down from €18,645 year-over-year.

• Depreciation and amortization totaled €60,129, nearly unchanged from H1 2025.

• Cash at period end was €256, compared to €475 at the end of H1 2025.

Outlook and guidance

• Management believes the operating environment remains favorable for growth and expects to continue raising capital for strategic development.

• Investor interest in financing projects with strong potential is stable, though fundraising is more time-consuming.